Neonatal Bisphenol A Exposure Affects the IgM Humoral Immune Response to 4T1 Breast Carcinoma Cells in Mice

被引:7
|
作者
Hernandez Avila, Ricardo [1 ]
Palacios-Arreola, Margarita I. [2 ]
Nava-Castro, Karen E. [2 ]
Morales-Montor, Jorge [1 ]
Ostoa-Saloma, Pedro [1 ]
机构
[1] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, AP 70228, Mexico City 04510, DF, Mexico
[2] Univ Nacl Autonoma Mexico, Ctr Ciencias Atmosfera, Dept Ciencias Ambientales, Lab Genotoxicol & Mutagenesis Ambientales, Mexico City 04510, DF, Mexico
关键词
BPA; IgM; 4T1; cells; ACTIVATED RECEPTOR-GAMMA; ENDOCRINE DISRUPTORS; INTERFERON-GAMMA; SALMONELLA; GALECTIN-1;
D O I
10.3390/ijerph16101784
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Bisphenol A (BPA) is an endocrine disruptor of estrogenic nature. During the early stages of development, any exposure to BPA can have long-term effects. In this work, we study the potential alterations to the humoral antitumor immune (IgM) response in adult life after a single neonatal exposure to BPA. Female syngeneic BALB/c mice were exposed to a single dose of BPA of 250 g/kg. Once sexual maturity was reached, a breast tumor was induced. After 25 days, the serum was obtained, and the populations of B cells in the spleen and lymph nodes were analyzed by flow cytometry. The reactivity of IgM was evaluated by 2D immunoblots. No significant changes were found in the B cell populations in the peripheral lymph nodes and the spleen. The level of ER expression was not significantly different. However, the IgM reactivity was affected. In individuals treated with BPA, a decrease in the number of IgMs that recognize tumor antigens was observed. The possibility that these antibodies are the high affinity products of the adaptive response is discussed. The recognition of IgG was also evaluated but a null recognition was found in the controls as in the individuals treated with the 4T1 cells.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Mono- and Combined Therapy of Metastasizing Breast Carcinoma 4T1 with Zoledronic Acid and Doxorubicin
    Baklaushev, V. P.
    Grinenko, N. F.
    Yusubalieva, G. M.
    Gubskii, I. L.
    Burenkov, M. S.
    Rabinovich, E. Z.
    Ivanova, N. V.
    Chekhonin, V. P.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2016, 161 (04) : 580 - 586
  • [42] Cancer Progression Is not Different in Mice of Different Gender Inoculated With Cells of the Triple-Negative 4T1 Breast Cancer Model
    Albores-Mendez, Exsal Manuel
    Casanas-Pimentel, Rocio Guadalupe
    Reyes-Chacon, Indira Raquel
    Cubas, Juan Maldonado
    Lopez-Cruz, Jaime
    Rincon-Huerta, Jorge Alberto
    Camacho-Ibarra, Alejandro
    San Martin-Martinez, Eduardo
    WORLD JOURNAL OF ONCOLOGY, 2022, 13 (05) : 249 - 258
  • [43] Effect of Autologous Dendritic Cell Vaccine and Anti-MDSC Treatment Against 4T1 Breast Cancer Cells in Mice
    Fournier, Pierrick
    Luna, Paloma Almeida
    Arrellano, Danna
    Jimenez, Samanta
    Juarez, Patricia
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 22 - 22
  • [44] Dying tumor cells (tumor debris) stimulate the growth of 4T1 breast cancer tumor in female athymic nude mice
    Roomi, M. Waheed
    Niedzwiecki, Aleksandra
    Rath, Matthias
    CANCER RESEARCH, 2018, 78 (13)
  • [45] Elimination of the chemotherapy resistant subpopulation of 4T1 mouse breast cancer by haploidentical NK cells cures the vast majority of mice
    Frings, Peter W. H.
    Van Elssen, Catharina H. M. J.
    Wieten, Lotte
    Matos, Catarina
    Hupperets, Pierre S. J. G.
    Schouten, Harry C.
    Bos, Gerard M. J.
    van Gelder, Michel
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 130 (03) : 773 - 781
  • [46] Elimination of the chemotherapy resistant subpopulation of 4T1 mouse breast cancer by haploidentical NK cells cures the vast majority of mice
    Peter W. H. Frings
    Catharina H. M. J. Van Elssen
    Lotte Wieten
    Catarina Matos
    Pierre S. J. G. Hupperets
    Harry C. Schouten
    Gerard M. J. Bos
    Michel van Gelder
    Breast Cancer Research and Treatment, 2011, 130 : 773 - 781
  • [47] Breast Tumor Targeting in Mice Bearing 4T1 Tumor with Labeled CXCR4 Antagonist Analogue
    Azadeh Mikaeili
    Mostafa Erfani
    Mostafa Goudarzi
    Omid Sabzevari
    International Journal of Peptide Research and Therapeutics, 2021, 27 : 2449 - 2457
  • [48] Genistein Enhances Doxorubicin Cytotoxic Activity and Inhibit Cells Migration on 4T1 Breast Cancer Cells
    Jenie, Riris I.
    Amalina, Nur D.
    Utomo, Rohmad Y.
    Ilmawati, Gagas P. N.
    Meiyanto, Edy
    CANCER SCIENCE, 2018, 109 : 867 - 867
  • [49] Breast Tumor Targeting in Mice Bearing 4T1 Tumor with Labeled CXCR4 Antagonist Analogue
    Mikaeili, Azadeh
    Erfani, Mostafa
    Goudarzi, Mostafa
    Sabzevari, Omid
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2021, 27 (04) : 2449 - 2457
  • [50] Hesperidin Increases Cytotoxic Effect of Doxorubicin and Inhibits Cells Migration on 4T1 Breast Cancer Cells
    Amalina, Nur D.
    Ilmawati, Gagas P. N.
    Handayani, Sri
    Utomo, Rohmad Y.
    Jenie, Riris I.
    Meiyanto, Edy
    CANCER SCIENCE, 2018, 109 : 364 - 364